SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RXSD Rexall Sundown

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andy Parham who wrote (18)6/17/1998 6:41:00 PM
From: Dorine Essey   of 327
 
Three Months Ended % Nine Months Ended % May 31, Increase May 31, Increase

1998 1997 1998 1997

Net sales $150,979 $75,018 101.3% $377,188 $202,044 86.7%
Cost of sales 65,197 28,485 128.9% 157,551 78,286 101.3%
Gross profit 85,782 46,533 84.3% 219,637 123,758 77.5%
Selling, general
and administrative
expenses 55,920 32,935 69.8% 145,488 86,288 68.6%
Operating income 29,862 13,598 119.6% 74,149 37,470 97.9%
Other income, net 1,109 976 13.6% 3,185 2,858 11.4%
Income before
income tax
provision 30,971 14,574 112.5% 77,334 40,328 91.8%
Income tax
provision 11,591 4,862 138.4% 27,781 14,052 97.7%

Net income $19,380 $9,712 99.5% $49,553 $26,276 88.6%

Pro forma net
income $19,380 9,539 103.2% $48,611 $25,794 88.5%

Pro forma income
per common share:
Basic $0.27 $0.14 $0.69 $0.38
Diluted $0.26 $0.13 $0.66 $0.37

Weighted average
common shares
outstanding:
Basic 71,372 69,638 70,950 67,330
Diluted 74,180 71,558 73,621 69,678

(1) Pro forma net income reflects a pro forma tax provision for Richardson Labs, Inc. for periods prior to
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext